Uganda on track to pass ‘biotech bill’ that should pave way for GMO crop commercialization

a eec o

Uganda’s long-awaited national Biotechnology and Biosafety Bill was delayed again yesterday, but is likely to be passed next Tuesday [Oct. 3], according to the nation’s Minister of Science Technology and Innovation.

The bill, which would create a process for the nation to commercialize and cultivate genetically engineered crops, was scheduled for action by Parliament yesterday. But Science Technology and Innovation Minister Elioda Tumwesigye requested a delay, citing lack of readiness on his part. The speaker of the Parliament yielded to his request.

Screen Shot at AM
Uganda Science Technology and Innovation Minister Elioda Tumwesigye. (Photo by Isaac Ongu)

Despite the absence of a biosafety law, Uganda follows only South Africa in the number of Confined Field Trials conducted to test the viability of GE crops in Africa. The ongoing trials include virus resistance in cassava; insect resistance in maize; herbicide tolerance in soybean; late blight resistance in potato; nitrogen efficiency, water efficiency and salt tolerance in rice; wilt resistance in banana; beta carotene enhancement in banana; and black sigatoka resistance in banana. Most biotech research projects are waiting for the law to carry out the final trials before applying to the National Biosafety Committee for environmental release and commercialization.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Uganda likely to pass its Biotech Bill next week

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.